L
32.40
0.15 (0.47%)
| 前收盘价格 | 32.25 |
| 收盘价格 | 32.05 |
| 成交量 | 1,073,010 |
| 平均成交量 (3个月) | 1,202,517 |
| 市值 | 5,980,090,880 |
| 预期市盈率 (P/E Forward) | 19.46 |
| 价格/销量 (P/S) | 7.44 |
| 股市价格/股市净资产 (P/B) | 5.76 |
| 52周波幅 | |
| 利润日期 | 12 Nov 2025 |
| 营业毛利率 | -29.95% |
| 营业利益率 (TTM) | -25.97% |
| 稀释每股收益 (EPS TTM) | -1.18 |
| 季度收入增长率 (YOY) | 107.50% |
| 总债务/股东权益 (D/E MRQ) | 35.65% |
| 流动比率 (MRQ) | 5.20 |
| 营业现金流 (OCF TTM) | -263.30 M |
| 杠杆自由现金流 (LFCF TTM) | -202.32 M |
| 资产报酬率 (ROA TTM) | -8.77% |
| 股东权益报酬率 (ROE TTM) | -20.00% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Legend Biotech Corporation | 看跌 | 看跌 |
AIStockmoo 评分
1.8
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.75 |
|
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 1.31% |
| 机构持股比例 | 47.92% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Braidwell Lp | 30 Jun 2025 | 2,542,104 |
| Matthews International Capital Management Llc | 30 Sep 2025 | 1,028,447 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 83.00 (Morgan Stanley, 156.17%) | 购买 |
| 中 | 76.00 (134.57%) | |
| 低 | 60.00 (HC Wainwright & Co., 85.19%) | 购买 |
| 平均值 | 72.40 (123.46%) | |
| 总计 | 5 购买 | |
| 平均价格@调整类型 | 34.58 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 17 Oct 2025 | 60.00 (85.19%) | 购买 | 31.96 |
| JP Morgan | 09 Oct 2025 | 76.00 (134.57%) | 购买 | 32.22 |
| 25 Aug 2025 | 78.00 (140.74%) | 购买 | 34.60 | |
| Cantor Fitzgerald | 27 Aug 2025 | 66.00 (103.70%) | 购买 | 34.72 |
| Morgan Stanley | 12 Aug 2025 | 83.00 (156.17%) | 购买 | 36.99 |
| RBC Capital | 12 Aug 2025 | 77.00 (137.65%) | 购买 | 36.99 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合